Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Balancing risk and reward: a rat model of risky decision making.

Simon NW, Gilbert RJ, Mayse JD, Bizon JL, Setlow B.

Neuropsychopharmacology. 2009 Sep;34(10):2208-17. doi: 10.1038/npp.2009.48.

2.

Dissociable roles for the basolateral amygdala and orbitofrontal cortex in decision-making under risk of punishment.

Orsini CA, Trotta RT, Bizon JL, Setlow B.

J Neurosci. 2015 Jan 28;35(4):1368-79. doi: 10.1523/JNEUROSCI.3586-14.2015.

3.

Sex differences in a rat model of risky decision making.

Orsini CA, Willis ML, Gilbert RJ, Bizon JL, Setlow B.

Behav Neurosci. 2016 Feb;130(1):50-61. doi: 10.1037/bne0000111.

PMID:
26653713
4.

Affective and cognitive mechanisms of risky decision making.

Shimp KG, Mitchell MR, Beas BS, Bizon JL, Setlow B.

Neurobiol Learn Mem. 2015 Jan;117:60-70. doi: 10.1016/j.nlm.2014.03.002.

5.

Perturbations in different forms of cost/benefit decision making induced by repeated amphetamine exposure.

Floresco SB, Whelan JM.

Psychopharmacology (Berl). 2009 Aug;205(2):189-201. doi: 10.1007/s00213-009-1529-0.

PMID:
19365622
6.

Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats.

Mitchell MR, Vokes CM, Blankenship AL, Simon NW, Setlow B.

Psychopharmacology (Berl). 2011 Dec;218(4):703-12. doi: 10.1007/s00213-011-2363-8.

7.

Dopaminergic modulation of risk-based decision making.

St Onge JR, Floresco SB.

Neuropsychopharmacology. 2009 Feb;34(3):681-97. doi: 10.1038/npp.2008.121.

8.

Receptor-specific modulation of risk-based decision making by nucleus accumbens dopamine.

Stopper CM, Khayambashi S, Floresco SB.

Neuropsychopharmacology. 2013 Apr;38(5):715-28. doi: 10.1038/npp.2012.240.

9.

Noradrenergic modulation of risk/reward decision making.

Montes DR, Stopper CM, Floresco SB.

Psychopharmacology (Berl). 2015 Aug;232(15):2681-96. doi: 10.1007/s00213-015-3904-3.

PMID:
25761840
10.

Orbitofrontal or accumbens dopamine depletion does not affect risk-based decision making in rats.

Mai B, Hauber W.

Cogn Affect Behav Neurosci. 2015 Sep;15(3):507-22. doi: 10.3758/s13415-015-0353-8.

PMID:
25860659
11.

Dopaminergic modulation of risky decision-making.

Simon NW, Montgomery KS, Beas BS, Mitchell MR, LaSarge CL, Mendez IA, BaƱuelos C, Vokes CM, Taylor AB, Haberman RP, Bizon JL, Setlow B.

J Neurosci. 2011 Nov 30;31(48):17460-70. doi: 10.1523/JNEUROSCI.3772-11.2011.

12.
13.

Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.

Larkin JD, Jenni NL, Floresco SB.

Psychopharmacology (Berl). 2016 Jan;233(1):121-36. doi: 10.1007/s00213-015-4094-8.

PMID:
26432096
14.

Prefrontal cortical contribution to risk-based decision making.

St Onge JR, Floresco SB.

Cereb Cortex. 2010 Aug;20(8):1816-28. doi: 10.1093/cercor/bhp250.

15.

Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making.

St Onge JR, Abhari H, Floresco SB.

J Neurosci. 2011 Jun 8;31(23):8625-33. doi: 10.1523/JNEUROSCI.1020-11.2011.

16.

Modeling risky decision making in rodents.

Simon NW, Setlow B.

Methods Mol Biol. 2012;829:165-75. doi: 10.1007/978-1-61779-458-2_10. Review.

17.

Dopaminergic and glutamatergic regulation of effort- and delay-based decision making.

Floresco SB, Tse MT, Ghods-Sharifi S.

Neuropsychopharmacology. 2008 Jul;33(8):1966-79.

19.

Testosterone enhances risk tolerance without altering motor impulsivity in male rats.

Cooper SE, Goings SP, Kim JY, Wood RI.

Psychoneuroendocrinology. 2014 Feb;40:201-12. doi: 10.1016/j.psyneuen.2013.11.017.

20.

Intact risk-based decision making in rats with prefrontal or accumbens dopamine depletion.

Mai B, Hauber W.

Cogn Affect Behav Neurosci. 2012 Dec;12(4):719-29. doi: 10.3758/s13415-012-0115-9.

PMID:
22923036
Items per page

Supplemental Content

Support Center